Danazol: endocrine and endometrial effects
Danazol therapy at 200-800 mg daily did not alter LH-FSH, prolactin, TSH, TBG, thyroxine, cortisol, or androstenedione but modestly decreased estrogens, increased androgens, and caused endometrial atrophy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (27)
- Endogenous Steroid Hormone Concentrations and Risk of Endometriosis in Nurses' Health Study II 2022
- Androgens Upregulate Endometrial Epithelial Progesterone Receptor Expression: Potential Implications for Endometriosis 2017
- Endometriosis for the colorectal surgeon 2010
- Danazol regulates the functions of normal human endometrial stromal cell subpopulations by modifying endometrial cytokine networks 2009
- Modern Medical Therapy of Endometriosis 2004
- The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: a review of clinical studies 2002
- Endometriosis and Pelvic Pain 1998
- Danazol enhances Fas-mediated apoptosis in human endometrial epithelial cells within normal physiology 1998
- Danazol versus a gonadotropin-releasing hormone agonist as preoperative preparation for hysteroscopic metroplasty 1996
- Adrenal steroids in serum during danazol therapy, taking into account cross-reactions between danazol metabolites and serum androgens 1993
- Vaginal patterns during danazol and buserelin acetate therapy for endometriosis: structural and ultrastructural study 1993
- Provocative tests of prolactin before, during and after long-term danazol treatment in patients with endometriosis 1992
- Endometrial patterns during therapy with danazol or gestrinone for endometriosis: structural and ultrastructural study 1992
- Tissue factors influencing growth and maintenance of endometriosis 1991
- Danazol stimulates the release of follicle-stimulating hormone and inhibits the release of prolactin in vitro studies on rat pituitary cell cultures 1989
- Genital bleeding during the administration of danazol 1988
- Danazol inhibits steroidogenesis by the human ovary in vivo 1986
- Dosage-related effects of danazol on sex hormone binding globulin and free and total androgen levels 1986
- Human endometrium transplanted into nude mice. Histologic effects of various steroid hormones 1985
- Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone 1985
- Short-term effects of danazol on endometrial histology 1984
- Cytosol estrogen and progestin receptor concentrations and 17 beta-hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue. Effects of hormonal treatment 1984
- Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone 1984
- Peripheral androgen levels in danazol-treated premenopausal women 1983
- Effects of ethinylestradiol and danazol on embryo survival and implantation in mated beagle bitches 1983
- Free testosterone levels during danazol therapy 1983
- Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity 1982
Source provenance
- europepmc
- last seen: 2026-10-11T09:27:45.537177+00:00
- openalex
- last seen: 2026-05-10T10:26:15.221776+00:00
- pubmed
- last seen: 2026-10-08T21:58:02.984372+00:00